Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...
s investments, employment, and potential conflicts of interest. They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics.
Amid a rapidly evolving macroenvironment, Takeda is changing up its R&D priorities and investment strategy ... M.D., Ph.D., told Fierce Biotech at the annual J.P. Morgan Healthcare Conference ...
(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has made two separate investments as part of series A and C funding rounds in two clinical-stage firms. RTW Biotech, an investment ...